Home › Products › Oncology › Olzapar 150mg Tablet
Olzapar 150mg Tablet
Salt Composition: OLAPARIB
- Manufacturer: DELARC PHARMACEUTICALS
- Pack Size: 60 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Strength: 150MG
- Prescription Required
- Storage: Store Olzapar 150mg Tablet Tablet in the original package at room temperature (20°C to 25°C). Keep it out of reach from children.
₹7953.00₹53019.00
Inclusive of all taxes
Product Introduction
Olzapar 150mg Tablet is a PARP (Poly Adenosine Diphosphate-Ribose Polymerase) inhibitor containing the active ingredient Olaparib. It belongs to the class of cancer medications and is indicated for treatment of pancreatic and prostate cancer. The medication may be administered as monotherapy or in combination with other anticancer agents.
Do not take Olzapar 150mg Tablet if you are allergic to Olaparib or any other ingredient in the formulation. Seek immediate medical attention if you develop breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing during treatment.
Your doctor will order blood tests before initiating treatment and monthly thereafter, as this medicine may reduce red blood cell, white blood cell, and platelet counts. Inform your healthcare provider before starting treatment if you have a history of lung, liver, heart, or kidney disease.
This medication is not recommended during pregnancy, as it may harm the fetus and cause miscarriage. Women of reproductive potential should undergo pregnancy testing before commencing treatment. Contraception should be continued for at least six months after completion of treatment.
Breastfeeding is not advised during treatment, as it is unknown whether Olzapar 150mg Tablet passes into breast milk. Men should not donate sperm for at least 3 months after treatment completion.
Inform your doctor of all medications you are taking, including prescription medicines, over-the-counter drugs, vitamins, and supplements.
Uses
Treatment of Prostate cancer Metastatic Pancreatic cancer
How it works
Olzapar 150mg Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Olzapar 150mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
How to Use
A healthcare professional will prescribe the medicine to you in a hospital setting. Olzapar 150mg Tablet is available to be taken with or without food, as directed by your healthcare provider. The dose will be decided by your healthcare professional based on your conditions. Avoid crushing, opening, or dissolving the tablet; swallow it whole with a glass of water. Take the Olzapar 100mg tablet at the same time every day.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common: Shortness of breath Nausea Vomiting Fatigue Dyspepsia Loss of appetite Dizziness Diarrhoea Headache Serious: Neutropenia Acute myeloid leukemia Leukopenia Thrombocytopenia Lung problems
Expert Tips
Olzapar 150mg Tablet can lower blood cell counts, thus it's best to get blood tests done at regular intervals. When undergoing this therapy, stay out of direct sunlight and wear sunscreen with an SPF of at least 50 before going outside. Olzapar 150mg Tablet should not be stopped without first talking to your doctor. When using this medication, stay away from grapefruit juice as it may raise your blood levels of the drug. It is recommended to inform your doctor about other anticancer drugs you have been taking. It's critical to maintain a sufficient fluid intake because dehydration can exacerbate symptoms such as diarrhea and other gastrointestinal disorders. Even if you feel better or see a change in your symptoms, you should still talk to your doctor before stopping Olzapar 150mg Tablet. Remember to attend all scheduled appointments and follow-up visits with your healthcare provider to ensure your treatment is effective and any side effects are managed appropriately. With proper monitoring and management, Olzapar 150mg Tablet can be an effective treatment option for certain types of cancer.
References
- Lynparza, United States Food and Drug Administration (USFDA), [Revised on May 2020], [Accessed on March 2024], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208558s014lbl.pdf
- AstraZeneca UK Limited, European Medicines Compendium (emc), [Revised on August 2023], [Accessed on March 2024], https://www.medicines.org.uk/emc/files/pil.9204.pdf
- AstraZeneca Pharmaceuticals LP, [Revised on November 2023], [Accessed on March 2024], https://den8dhaj6zs0e.cloudfront.net/50fd68b9-106b-4550-b5d0-12b045f8b184/00997c3f-5912-486f-a7db-930b4639cd51/00997c3f-5912-486f-a7db-930b4639cd51_viewable_rendition__v.pdf
Safety Advice
Pregnancy: unsafe It is not recommended to take Olzapar 150mg Tablet during pregnancy as it may harm your unborn baby. It is necessary to inform your doctor if you are pregnant or planning to become pregnant.
Lungs: Consult your doctor It is unknown whether Olzapar 150mg Tablet is safe in individuals with liver disorders. Inform your physician if you have any liver problems before starting the treatment.
Breastfeeding: Consult your doctor It is unknown whether Olzapar 150mg Tablet Tablet passes into the breast milk. It is not recommended to nurse a child during and after 1 month of completion of therapy. Please consult your doctor before breastfeeding.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.